Press Releases

2022

• QPS Opens Additional Preclinical Research Facility In Taipei, Taiwan

• QPS Further Enhances Its Global Medical, Regulatory and Biotech CRO Services Capabilities

• Lipum has entered a partnership with QPS Netherlands B.V. for its first clinical trial with SOL-116

• QPS Holdings LLC Announces a New Director of Neuropharmacology

2021

• QPS Supports COVID-19 Vaccine Development In Taiwan

• QPS Awarded Five 2021 CRO Leadership Awards

2020

• QPS Missouri Projected to Pay $1 Million to Local Participants

• QPS Awarded Two 2020 CRO Leadership Awards

• QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development

• QPS Announces Novel Coronavirus/COVID-19 Testing Capability

• QPS Assembles an Access Restricted Bioanalysis Lab to Support Drug Companies in the Fight Against Novel Coronavirus

• QPS Forms Partnership with UMCG and G-CURE for Cardiovascular Drug Development

2019

• QPS Expands Its Global Footprint with New Facilities in the Netherlands, India, and China

• QPS Announces Continuing Growth in Asia, Hosts 28 Taiwanese Delegates at Delaware Headquarters

• QPS Receives CRO Leadership Award, Recognized for Reliability

• QPS Announces 170 Percent Revenue Growth For In Vitro Studies Across Europe

• QPS Outpaces Market Growth for Phase I Clinical Trials, Adopts ClinSpark to Support Rapid Global Expansion

• Brexit Leads to 25 Percent Decline in UK Clinical Trials: QPS Netherlands Ready to Take on Clinical Trials that Require Relocation, Manage New Projects

• QPS Expands Translational Medicine Unit Three-Fold to Increase Support for Biopharmaceutical, Biotechnology and CRO Partners, Address Market Demand for Gene Therapy

• QPS Announces Launch of New Brand Identity, Celebrates 24 Years of Growth

2018

• QPS Expands U.S.-Based Phase I Clinical Trial Capabilities to Support the Growing Needs of Its Pharmaceutical, Biotechnology and CRO Partners

• QPS Neuro and Pronexus Analytical announce formation of a joint partnership

2017

• QPS Delaware Greatly Expands Translational Medicine Capabilities 

• Kancera AB Selects QPS to Manage First-in-Human Study with KAND567

• QPS Finalizes a Five Year Senior Credit Facility with Three Leading US Financial Institutions

• Acticor Biotech has selected its Contract Research Organisation to manage Clinical Study Phase I

2016

• QPS and G-CURE announce partnership

• Dr. Ben Chien, CEOs of QPS and Foresee Pharma, Named an EY Entrepreneur Of The Year^® 2016 Finalist for Greater Philadelphia

• SCIEX and QPS Holdings Enter Collaboration to Establish the BioBA Solution for Bioanalysis of Biologics

• QPS, Holdings LLC and Samsara Sciences, Inc. announce long-term partnership